The Conafay Group
Erik Wolf has a diverse work experience spanning over two decades. Erik started their career as a graduate student at the Human Engineering Research Laboratories in 2000. From 2007 to 2012, they worked as a Research Engineer at the Henry M Jackson Foundation for the Advancement of Military Medicine. In 2012, they joined Walter Reed National Military Medical Center as a Senior Research Biomedical Engineer and worked there until 2015. From 2015 to 2020, they worked as Neuromusculoskeletal Injury Rehabilitation Program Manager at the Clinical and Rehabilitative Medicine Research Program. In 2020, they joined the Office of the Principal Assistant for Research and Technology as Science and Technology Portfolio Analysis and Integration. Currently, they are working as Vice President at The Conafay Group since September 2021.
Erik Wolf earned a Bachelor's Degree in Bioengineering and Biomedical Engineering from the University of Pittsburgh in 2000. Erik then pursued a Master of Science (MS) in the same field from 2000 to 2003, and subsequently earned a Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering from the same institution in 2006.
This person is not in any offices
The Conafay Group
The Conafay Group works with life science companies and organizations to develop and implement government funding and public policy strategies. We also bridge ties to philanthropic, non-‐profit, academic and commercial entities to enhance client outcomes. Working on behalf of our clients, we create and execute dynamic strategies that facilitate: • Non-Dilutive Funding • Health Policy Advocacy • Ally Development • Federal Government Relations • Public-Private Partnerships • Federal Marketing • Coalition Management • Business-to-Business Partnering TCG specializes in representing biomedical technologies and therapeutics before the federal government and associated stakeholders. Our client successes involve for-profit and non-profit entities in areas of funding, research and public policy. We identify and target novel funding opportunities, synergies between client technology and federal/private needs, and policy issues that affect life sciences companies. Our expertise provides our clients an advantage over competitors in the federal and non-federal funding market. Since 2003, our team has helped clients secure nearly $1B in non-dilutive funding and services. Led by Stephen Conafay, TCG is a team of engineers, scientists, and policy experts, as well as former industry executives and federal staff, who offer a wealth of scientific and policy expertise in issues relevant to the life sciences and biotechnology industry. Applying this collective expertise, we have an intimate understanding of the non-dilutive funding landscape, healthcare and innovation policy, federal government needs and priorities, and commercial/institutional partnering opportunities. Our strength lies in putting this knowledge, and our familiarity with the science behind our clients’ technology, to work for our clients. Through our team‐based approach, we are able to deliver fully integrated government relations strategies that enable our clients to achieve greater success.